DOCSLIB.ORG

1 Bekanntmachung in Bezug Auf Die Folgenden Long Bzw. Short Mini

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
1 Bekanntmachung in Bezug Auf Die Folgenden Long Bzw. Short Mini Bekanntmachung in Bezug auf die folgenden Long bzw. Short Mini Future Turbo Optionsscheine der Goldman, Sachs & Co. Wertpapier GmbH Hinsichtlich der unten genannten Long bzw. Short Mini Future Turbo Optionsscheine ist gemäß der Optionsscheinbedingungen ein Knock-Out Ereignis eingetreten, da die jeweilige Knock-Out Barriere erreicht oder unterschritten (bei Long Optionsscheinen) bzw. erreicht oder überschritten (bei Short Optionsscheinen) wurde. Die betroffenen Optionsscheine werden wie folgt abgerechnet: Datum des Knock-Out WKN Basiswert Optionstyp Knock-Out Barriere Knock-Out Auszahlungsbetrag je Ereignisses Optionsschein in EUR GC8Q8Y Adobe Inc. Short USD 661,3329 27. August 2021 1,61 GF3PNC Salesforce.com, Inc. Short USD 269,1353 26. August 2021 0,66 GF4568 Salesforce.com, Inc. Short USD 274,388 26. August 2021 0,67 GF8V4U NASDAQ-100 Index® Short USD 15415,055 27. August 2021 2,67 GF9TJY S&P 500® Index Short USD 4508,169 27. August 2021 0,78 GH01AV AEX-Index® Short EUR 785,927 27. August 2021 0,15 GH0MXM NASDAQ-100 Index® Short USD 15438,499 27. August 2021 2,67 GH0XTZ Amgen Inc. Long USD 220,5603 26. August 2021 0,35 GH0XUF Broadcom Inc Short USD 494,9438 27. August 2021 1,2 GH1075 Netflix, Inc. Short USD 556,4432 27. August 2021 0,18 GH107U Netflix, Inc. Short USD 559,0442 27. August 2021 0,18 GH108E Netflix, Inc. Short USD 561,6452 27. August 2021 0,18 GH1N5P Aegon N.V. Short EUR 4,268 26. August 2021 0,08 GH1U7P Salesforce.com, Inc. Short USD 263,9393 26. August 2021 0,64 GH1U7R Salesforce.com, Inc. Short USD 265,7059 26. August 2021 0,65 GH2P7H The Kraft Heinz Company Long USD 36,2485 26. August 2021 0,11 GH2P7P The Kraft Heinz Company Long USD 36,0479 26. August 2021 0,11 GH2P7Q The Kraft Heinz Company Long USD 35,8473 27. August 2021 0,11 GH4JG2 AT&T Inc. Long USD 26,9913 27. August 2021 0,04 GH6U2U AT&T Inc. Long USD 27,0694 26. August 2021 0,04 GH7A3T AT&T Inc. Long USD 27,2077 26. August 2021 0,04 GH7CX7 ASML Holding N.V. Short EUR 695,1364 27. August 2021 1,23 GH7G58 Nvidia Corporation Short USD 225,2295 27. August 2021 3,85 GH7GB1 Wacker Chemie AG Short EUR 149,2285 26. August 2021 0,57 GH7GB2 Wacker Chemie AG Short EUR 149,9055 27. August 2021 0,57 1 Datum des Knock-Out WKN Basiswert Optionstyp Knock-Out Barriere Knock-Out Auszahlungsbetrag je Ereignisses Optionsschein in EUR GH7K00 Booking Holdings Inc. Short USD 2308,6367 27. August 2021 0,35 GH7MGV ThyssenKrupp AG Short EUR 9,1483 26. August 2021 0,46 GH7RXS The Charles Schwab Corporation Short USD 75,5677 27. August 2021 0,19 GH83N8 AIXTRON SE Short EUR 25,1825 27. August 2021 1,25 GH86CE JPMorgan Chase & Co. Short USD 163,6999 26. August 2021 0,25 GH86DD JPMorgan Chase & Co. Short USD 162,9379 26. August 2021 0,25 GH88KG MasterCard Incorporated Long USD 353,2412 26. August 2021 0,81 GH8J7W ThyssenKrupp AG Short EUR 9,0837 26. August 2021 0,45 GH8L6J Salesforce.com, Inc. Short USD 267,1276 26. August 2021 0,65 GH8L71 Salesforce.com, Inc. Short USD 271,4822 26. August 2021 0,66 GH8XEP Alphabet Inc. - Class C Short USD 2882,0056 27. August 2021 0,7 GH8ZZR QIAGEN N.V. Short EUR 46,732 26. August 2021 0,13 GH90A7 Hugo Boss AG Long EUR 46,9327 26. August 2021 0,13 GH9A8A QIAGEN N.V. Short EUR 47,002 27. August 2021 0,13 GH9BZ1 Alphabet Inc. - Class C Short USD 2897,954 27. August 2021 0,7 GH9KAD Facebook, Inc. Short USD 373,0165 27. August 2021 0,91 GH9KC1 Facebook, Inc. Short USD 371,261 27. August 2021 0,9 GH9KFZ STMicroelectronics N.V. Short EUR 37,0902 27. August 2021 1,44 GH9KGC STMicroelectronics N.V. Short EUR 37,2725 27. August 2021 1,45 GH9NWS JD.com Inc Short USD 77,05 26. August 2021 0,26 GH9NYR JD.com Inc Short USD 76,51 26. August 2021 0,26 GH9P04 TeamViewer AG Short EUR 28,52 26. August 2021 0,14 GH9P05 TeamViewer AG Short EUR 28,65 26. August 2021 0,14 GH9P08 TeamViewer AG Short EUR 28,79 26. August 2021 0,14 GH9P0B TeamViewer AG Short EUR 28,92 26. August 2021 0,15 GH9P0J TeamViewer AG Short EUR 29,05 27. August 2021 0,15 GH9QSU Henkel AG & Co KGaA Long EUR 81,68 26. August 2021 0,15 GH9U01 ASML Holding N.V. Short EUR 699,06 27. August 2021 1,25 GH9U4W Alphabet Inc. - Class C Short USD 2865,38 27. August 2021 0,7 GH9W2R 1 Feinunze Gold, Feinheit mind. 0,995, LBMA Short USD 1817 27. August 2021 2,83 GH9WG8 Spotify Technology S.A. Short USD 227,79 27. August 2021 0,66 GH9YU0 Infineon Technologies AG Short EUR 36,12 27. August 2021 1,42 GH9ZML Puma SE Long EUR 104,49 26. August 2021 0,19 GH9ZNT Puma SE Long EUR 103,94 26. August 2021 0,19 GH9ZP0 Puma SE Long EUR 103,39 26. August 2021 0,19 ICE Brent Crude Oil Future (Generic Front Month GX01LE Short USD 71,54461 27. August 2021 1,84 Future) GX028B Peloton Interactive Inc. Short USD 118,43 26. August 2021 1,1 2 Datum des Knock-Out WKN Basiswert Optionstyp Knock-Out Barriere Knock-Out Auszahlungsbetrag je Ereignisses Optionsschein in EUR GX028D Autodesk, Inc. Long USD 321,8 26. August 2021 0,47 GX028J Autodesk, Inc. Long USD 313,18 26. August 2021 0,98 GX028K Autodesk, Inc. Long USD 311,43 26. August 2021 0,98 GX028M Autodesk, Inc. Long USD 309,7 26. August 2021 0,97 GX028P Autodesk, Inc. Long USD 314,89 26. August 2021 0,99 GX028S Autodesk, Inc. Long USD 316,61 26. August 2021 0,99 GX028T Autodesk, Inc. Long USD 320,07 26. August 2021 1 GX0295 Autodesk, Inc. Long USD 318,34 26. August 2021 1 GX02AH 1 Feinunze Silber, Feinheit mind. 0,999 Short USD 24,1 27. August 2021 0,63 GX02AL 1 Feinunze Silber, Feinheit mind. 0,999 Short USD 24 27. August 2021 0,57 GX02BL 1 Feinunze Silber, Feinheit mind. 0,999 Short USD 24,1 27. August 2021 0,58 GX02C6 1 Feinunze Silber, Feinheit mind. 0,999 Short USD 24 27. August 2021 0,62 GX0424 Peloton Interactive Inc. Short USD 117,18 26. August 2021 1,09 GX0439 Peloton Interactive Inc. Short USD 119,54 26. August 2021 1,11 GX04Z3 Infineon Technologies AG Short EUR 35,92 27. August 2021 1,42 GX04ZT Infineon Technologies AG Short EUR 35,75 27. August 2021 1,42 GX053N Advanced Micro Devices, Inc. Short USD 111,75 27. August 2021 0,59 GX054D AIXTRON SE Short EUR 24,99 27. August 2021 1,26 GX05R4 Beiersdorf AG Long EUR 101,04 26. August 2021 0,19 GX05RA Beiersdorf AG Long EUR 101,58 26. August 2021 0,19 GX05V3 AIXTRON SE Short EUR 24,85 27. August 2021 1,27 GX05VP AIXTRON SE Short EUR 25,31 27. August 2021 1,29 GX06YY Lam Research Corporation Short USD 606,89 27. August 2021 2,07 GX06ZA Lam Research Corporation Short USD 612,65 27. August 2021 2,09 GX070K Lam Research Corporation Short USD 609,76 27. August 2021 2,08 GX0717 Lam Research Corporation Short USD 604 27. August 2021 2,06 GX07L1 SolarEdge Technologies, Inc. Short USD 292,38 27. August 2021 0,87 GX07LR Amazon.com, Inc. Short USD 3325,41 26. August 2021 0,84 GX07LS Amazon.com, Inc. Short USD 3341,42 27. August 2021 0,84 NYMEX Light, Sweet Crude Oil Future (Generic Front GX08UF Short USD 69 27. August 2021 1,76 Month Future) GX09LN Cancom SE Short EUR 55,36 27. August 2021 0,22 GX09M7 K+S AG Short EUR 12,12 27. August 2021 0,36 GX09NA Deutsche Telekom AG Long EUR 18,38 27. August 2021 0,34 GX09P2 Texas Instruments Incorporated Short USD 189,95 27. August 2021 0,48 GX09WA Johnson & Johnson Long USD 173,3141 26. August 2021 0,28 GX0CS7 SolarEdge Technologies, Inc. Short USD 287,56 27. August 2021 0,87 GX0D3G eBay Inc. Short USD 76,1 27. August 2021 0,13 3 Datum des Knock-Out WKN Basiswert Optionstyp Knock-Out Barriere Knock-Out Auszahlungsbetrag je Ereignisses Optionsschein in EUR GX0D3J The Walt Disney Company Short USD 180,5 27. August 2021 0,3 GX0D6H Advanced Micro Devices, Inc. Short USD 110,06 27. August 2021 0,59 GX0D6P Advanced Micro Devices, Inc. Short USD 110,56 27. August 2021 0,59 GX0D6U Advanced Micro Devices, Inc. Short USD 111,07 27. August 2021 0,59 GX0FJV Vivendi S.A. Short EUR 32,84 26. August 2021 0,06 GX0FJX Varta AG Long EUR 130,16 27. August 2021 0,61 GX0FK3 Vivendi S.A. Short EUR 32,57 26. August 2021 0,06 GX0FL0 Vivendi S.A. Short EUR 31,75 26. August 2021 0,06 GX0FL4 Bilfinger SE Short EUR 29,82 27. August 2021 0,12 GX0FLZ Vivendi S.A. Short EUR 32,3 26. August 2021 0,06 GX0FP7 eBay Inc. Short USD 74,56 26. August 2021 0,12 GX0FQL eBay Inc. Short USD 74,91 26. August 2021 0,13 GX0FU9 Walmart Inc. Long USD 146,68 26. August 2021 0,24 GX0FUM Walmart Inc.
Load more

Recommended publications
  • Bedienungsanleitung Doro 8050
    Doro 8050 Deutsch 1 8 13 2 14 3 9 15 10 4 10 16 5 6 11 7 12 Diese Anleitung dient lediglich als Referenz. Das Gerät, einschließlich, jedoch nicht be- schränkt auf Farbe, Größe und Bildschirmlay- out, sowie das mitgelieferte Zubehör können variieren. Dies ist davon abhängig, welche Software und welches Zubehör in Ihrer Region erhältlich ist bzw. von Ihrem Netzbetreiber an- geboten wird. Bei Ihrem örtlichen Doro-Händ- ler können Sie weiteres Zubehör erhalten. Das mitgelieferte Zubehör bietet die beste Lei- stung für Ihr Telefon. 17 Hinweis! Alle Abbildungen dienen lediglich zu anschaulichen Zwecken und geben das Aussehen des Geräts möglicherweise nicht genau wieder. Übersicht 1. Headset-Anschluss, für Stan- 11. USB Typ C, zum Aufladen des dard-Headsets mit 3,5-mm- Akkus oder zum Anschluss an Telefonbuchse andere Geräte, z. B. einen 2. Ohrstück, für Telefonanrufe Computer mit dem Telefon am Ohr 12. Lautsprecher, für den 3. SIM-/SD-Kartenfach Freisprechmodus 4. Lautstärkeregler 13. Zweites Mikrofon 5. Touchdisplay (berührungs- 14. Rückseitenkamera empfindlicher Bildschirm) 15. Blitzlicht/Taschenlampe 6. Home-Taste 16. Notruftaste, muss vor Ver- 7. Mikrofon wendung eingerichtet wer- den. Weitere Informationen Frontkamera 8. , Selfie-Kamera sind im vollständigen Benut- 9. Näherungssensor, schaltet zerhandbuch zu finden das Touchdisplay aus, wenn 17. Ladestation (optionales das Telefon am Ohr gehalten Zubehör) wird 10. Ein-/Aus-Taste, zum Ein- und Ausschalten des Telefons drücken und gedrückt halten Deutsch Inhalt Einrichtung des Doro 8050 ...........................................................................
    [Show full text]
  • Retirement Strategy Fund 2060 Description Plan 3S DCP & JRA
    Retirement Strategy Fund 2060 June 30, 2020 Note: Numbers may not always add up due to rounding. % Invested For Each Plan Description Plan 3s DCP & JRA ACTIVIA PROPERTIES INC REIT 0.0137% 0.0137% AEON REIT INVESTMENT CORP REIT 0.0195% 0.0195% ALEXANDER + BALDWIN INC REIT 0.0118% 0.0118% ALEXANDRIA REAL ESTATE EQUIT REIT USD.01 0.0585% 0.0585% ALLIANCEBERNSTEIN GOVT STIF SSC FUND 64BA AGIS 587 0.0329% 0.0329% ALLIED PROPERTIES REAL ESTAT REIT 0.0219% 0.0219% AMERICAN CAMPUS COMMUNITIES REIT USD.01 0.0277% 0.0277% AMERICAN HOMES 4 RENT A REIT USD.01 0.0396% 0.0396% AMERICOLD REALTY TRUST REIT USD.01 0.0427% 0.0427% ARMADA HOFFLER PROPERTIES IN REIT USD.01 0.0124% 0.0124% AROUNDTOWN SA COMMON STOCK EUR.01 0.0248% 0.0248% ASSURA PLC REIT GBP.1 0.0319% 0.0319% AUSTRALIAN DOLLAR 0.0061% 0.0061% AZRIELI GROUP LTD COMMON STOCK ILS.1 0.0101% 0.0101% BLUEROCK RESIDENTIAL GROWTH REIT USD.01 0.0102% 0.0102% BOSTON PROPERTIES INC REIT USD.01 0.0580% 0.0580% BRAZILIAN REAL 0.0000% 0.0000% BRIXMOR PROPERTY GROUP INC REIT USD.01 0.0418% 0.0418% CA IMMOBILIEN ANLAGEN AG COMMON STOCK 0.0191% 0.0191% CAMDEN PROPERTY TRUST REIT USD.01 0.0394% 0.0394% CANADIAN DOLLAR 0.0005% 0.0005% CAPITALAND COMMERCIAL TRUST REIT 0.0228% 0.0228% CIFI HOLDINGS GROUP CO LTD COMMON STOCK HKD.1 0.0105% 0.0105% CITY DEVELOPMENTS LTD COMMON STOCK 0.0129% 0.0129% CK ASSET HOLDINGS LTD COMMON STOCK HKD1.0 0.0378% 0.0378% COMFORIA RESIDENTIAL REIT IN REIT 0.0328% 0.0328% COUSINS PROPERTIES INC REIT USD1.0 0.0403% 0.0403% CUBESMART REIT USD.01 0.0359% 0.0359% DAIWA OFFICE INVESTMENT
    [Show full text]
  • MDAX—2019 Supervisory Board Study Key Insights from This Year’S Analysis by Russell Reynolds Associates
    MDAX—2019 Supervisory Board Study Key insights from this year’s analysis by Russell Reynolds Associates Summary Over the past year, Germany's MDAX companies have experienced significant change. The number of companies in the index increased by 10, bringing the overall total to 60. Moreover, 11 "old economy" firms, including Jungheinrich, Krones, Leoni, Salzgitter and Schaeffler, were ousted by pharma, med and biotech risers, such as Evotec, Morphosys, Qiagen, Sartorius and Siemens Healthineers, as well as "new economy" powerhouses like Dialog, Nemetschek, Software AG, Telefonica D, and United Internet. This was also an exceptional election year, with 106 shareholder representative positions expiring. All positions were filled. A total of 67 board members were re-elected, while 36 were replaced. The three remaining roles were absorbed by changes to board sizes. Female shareholder representation surpasses 30 percent For the first time, the share of female shareholder representatives surpassed the required quota, reaching 30.6 percent. Including employee representatives, women now make up 32 percent of supervisory board members. A total of three boards are now chaired by women. However, there is still a major gender discrepancy concerning positions of power when comparing chairpersonships and especially executive board positions. Only four companies can boast more than 30 percent of female executives, while 40 MDAX companies do not have a single woman in a leadership role. Accelerated increase in digital directors The number of digital directors on MDAX supervisory boards showed a significant 30 percent year- on-year increase. However, digital expertise is still unevenly spread in the MDAX. Seven companies have three or more digital directors, while 57 percent of boards completely lack digital expertise.
    [Show full text]
  • Annual Financial Statements of Teamviewer Ag Fiscal Year 2020 2 3 15 74 16 61 17 75 51 28 65 29 39 60 60 63 64 40 48
    ANNUAL FINANCIAL STATEMENTS OF TEAMVIEWER AG FISCAL YEAR 2020 01_COMBINED MANAGEMENT REPORT 01 Group fundamentals ............................................................................................................... 3 02 Employees .............................................................................................................................. 15 03 Corporate responsibility ...................................................................................................... 16 04 Economic report ................................................................................................................... 17 05 Events after the reporting period ....................................................................................... 28 06 Opportunity and risk report .................................................................................................29 07 Outlook ...................................................................................................................................39 08 Remuneration report ............................................................................................................40 09 Takeover-related disclosures ...............................................................................................48 10 Corporate governance statement ........................................................................................ 51 11 Nonfinancial statement ........................................................................................................60
    [Show full text]
  • Sartorius Group 2016 Annual Report Order Intake and Sales Revenue Underlying EBITDA and Margin1) ¤ in Millions
    Sartorius Group 2016 Annual Report Order Intake and Sales Revenue Underlying EBITDA and Margin1) ¤ in millions 866.8 912.3 819.6 929.2 1,172.7 1,334.7 161.1 172.6 162.3 186.8 263.2 325.4 845.7 887.3 791.6 891.2 1,114.8 1,300.3 19.0 19.5 20.5 21.0 23.6 25.0 1,500 400 30 1,250 300 27 1,000 200 24 750 100 21 500 0 18 2012 2013 2013 2014 2015 2016 2012 2013 2013 2014 2015 2016 Continued operations Continued operations Q Order intake Q Underlying EBITDA in millions of ¤ QSales revenue Underlying EBITDA margin in % Key Figures All figures are given in millions of ¤ according 2016 2015 2014 2013 2013 2012 to the IFRS, unless otherwise specified restated Order intake, sales revenue and earnings Order intake 1,334.7 1,172.7 929.2 819.6 912.3 866.8 Sales revenue 1,300.3 1,114.8 891.2 791.6 887.3 845.7 Underlying EBITDA1) 325.4 263.2 186.8 162.3 172.6 161.1 Underlying EBITDA1) as a % of sales revenue 25.0 23.6 21.0 20.5 19.5 19.0 Relevant net profit for continuing operations2) 132.6 107.4 66.1 59.2 – – Relevant net profit2) 132.6 107.4 73.7 64.8 64.8 63.0 Research and development costs 59.4 52.5 43.63) 47.7 53.8 49.0 Financial data per share4) Earnings per share continued operations2) per ordinary share (in ¤) 1.93 1.57 0.96 0.86 – – per preference share (in ¤) 1.94 1.58 0.97 0.87 – – Earnings per share2) per ordinary share (in ¤) 1.93 1.59 1.07 0.95 0.95 0.92 per preference share (in ¤) 1.94 1.60 1.08 0.96 0.96 0.93 Dividends per ordinary share (in ¤) 0.455) 0.37 0.26 0.25 0.25 0.23 per preference share (in ¤) 0.465) 0.38 0.27 0.26 0.26 0.24 Balance
    [Show full text]
  • QIAGEN N.V., Venlo, Niederlande
    QIAGEN N.V., Venlo, Niederlande Einladung zur ordentlichen Hauptversammlung Wir laden hiermit unsere Aktionäre zur ordentlichen Hauptversammlung der QIAGEN N.V. am Dienstag, den 30. Juni 2020 um 15.00 Uhr am Sitz der Gesellschaft, Hulsterweg 82, 5912 PL Venlo, Niederlande, ein. Aufgrund der Corona Pandemie und um unsere Aktionäre und alle anderen Teilnehmer der ordentlichen Hauptversammlung bestmöglich zu schützen, findet die Hauptversammlung ausschließlich in virtueller Form statt und wird in englischer Sprache abgehalten. Aktionären wird folglich kein physischer Zutritt zur Hauptversammlung gewährt. Die Versammlung wird live per audio webcast auf der Internetseite der Gesellschaft unter www.qiagen.com übertragen. Hierfür ist eine vorherige Anmeldung nicht notwendig. Zusätzlich zu den jährlich wiederkehrenden Tagesordnungspunkten wird die ordentliche Hauptversammlung in diesem Jahr auch eine Reihe von Tagesordnungspunkten umfassen, die sich auf das empfohlene Angebot der Quebec B.V, einer hundertprozentigen Tochtergesellschaft von Thermo Fisher Scientific Inc., für den Erwerb aller Stammaktien der Gesellschaft, einschließlich aller zum Zeitpunkt der Abwicklung des Angebots bestehenden Nebenrechte, insbesondere der Gewinnanteilsberechtigung, gegen Zahlung einer unverzinslichen Bargegenleistung in Höhe von EUR 39,00 je Stammaktie. Die Fassung des Back-End-Beschlusses (Tagesordnungspunkt 18) ist eine der Angebotsbedingungen. Heute wurden die Angebotsunterlage und die gemeinsame begründete Stellungnahme von QIAGEN und dem Vorstand und dem Aufsichtsrat zum Übernahmeangebot veröffentlicht. Wir empfehlen Ihnen eindringlich, diese Dokumente sorgfältig durchzulesen, da sie wichtige Informationen über das Angebot enthalten. Die Tagesordnung der ordentlichen Hauptversammlung der Gesellschaft mit den Vorschlägen von Vorstand und Aufsichtsrat lautet wie folgt: Jährliche wiederkehrende Tagesordnungspunkte 1. Eröffnung 2. Bericht des Vorstands über das am 31. Dezember 2019 abgelaufene Geschäftsjahr 3.
    [Show full text]
  • Eurex Circular 043/14
    eurex circular 043/14 Date: 6 March 2014 Recipients: All Trading Participants of Eurex Deutschland and Eurex Zürich and Vendors Authorized by: Thomas Book Action required A. Single Stock Futures: Introduction of SSFs on Belgian, French, German, Italian, Spanish and Swiss underlyings; B. Equity options: Introduction of equity options on CompuGroup Medical AG, Flughafen Wien AG Inhaber-Aktien o.N. and Nemetschek AG Inhaber-Aktien o.N. Contact: Derivatives Trading Operations, T +49-69-211-1 12 10, Michael Durica, T +49-69-211-1 59 23 Content may be most important for: Attachments: Ü All departments 1. Updated Annexes A and B of the Contract Specifications for Futures Contracts and Options Contracts at Eurex Deutschland and Eurex Zürich 2. Market Maker Obligations (excerpt) Summary: The Management Board of Eurex Deutschland and the Executive Board of Eurex Zürich AG took the following decisions with effect from 10 March 2014: 1. Introduction of Single Stock Futures on Beneteau S.A. Actions Port. EO -,10, Société Foncière Lyonnaise SA Actions Port. EO 2, Carl Zeiss Meditec AG, Dt. Annington Immobilien SE Namens-Aktien o.N., CompuGroup Medical AG, CANCOM SE, Almirall S.A. Acciones Port. EO -,12, GameLoft SE Actions Port. EO 0,05, Helvetia Holding AG, KBC Ancora Actions au Port. o.N, LEG Immobilien AG, LPKF Laser & Electronics AG, C.M.B. (Cie Maritime Belge) SA Actions Nouvelles au Port.o.N., Nemetschek AG Inhaber-Aktien o.N., Norma Group SE, Telefonica Deutschland Holding, Swiss Prime Site AG, Sartorius AG, Temenos Group AG and Yoox S.p.A. Azioni nom.
    [Show full text]
  • Media R Elease
    Frankfurt/Main, 5 December 2018 Carl Zeiss Meditec AG to be included in MDAX Three changes in SDAX/ Changes to be effective as of 27 December 2018 On Wednesday, Deutsche Börse announced changes to its selection indices, which will become effective on 27 December 2018. The shares of Carl Zeiss Meditec AG will be included in the MDAX index and will replace the shares of CTS Eventim AG & CO. KGaA, which will be included in the SDAX index. The exclusion of CTS Eventim AG & CO. KGaA is based on the fast exit rule; Carl Zeiss Meditec AG is eligible for the index inclusion due to its market capitalisation and order book turnover. MDAX tracks the 60 largest and most liquid companies below DAX. The following changes will apply to SDAX: CTS Eventim AG & CO. KGaA, Knorr- Bremse AG and VARTA AG will be included. The shares of BayWa AG and DMG Mori AG will be deleted from the index, according to the fast exit rule. SDAX tracks the 70 next biggest and most actively traded companies after the MDAX. The constituents of the indices DAX and TecDAX remain unchanged. The next scheduled index review is 5 March 2019. DAX®, MDAX®, SDAX® and TecDAX® are registered trademarks of Deutsche Börse AG. Media Release About Deutsche Börse – Market Data + Services In the area of data, Deutsche Börse Group is one of the world’s leading service providers for the securities industry with products and services for issuers, investors, intermediaries, and data vendors. The Group’s portfolio covers the entire value chain in the financial business.
    [Show full text]
  • Incoming Letter: QIAGEN N.V
    WACHTELL, LIPTON , ROSEN & KATZ MARTIN LIPTON STEVEN A. COHEN 51 W E S T 52N D S T R E E T DAVID E. SHAPIRO SABASTIAN V. NILES HERBERT M. WACHTELL DEBORAH L. PAUL DAMIAN G. DIDDEN ALISON ZIESKE PREISS THEODORE N. MIRVIS DAVID C. KARP NEW YORK, N.Y. 1 0 0 1 9 - 6 1 5 0 IAN B OC Z K O TIJANA J. DVORNIC EDWARD D. HERLIHY RICHARD K. KIM MATTHEW M. GUEST JENNA E. LEVINE DANIEL A. NEFF JOSHUA R. CAMMAKER TELEPHONE: (212) 403 -1000 DAVID E. KAHAN RYAN A. McLEOD ANDREW R. BROWNSTEIN MARK GORDON DAVID K. LAM ANITHA REDDY MARC WOLINSKY JOSEPH D. LARSON FACSIMILE: (212) 403 -2000 BENJAMIN M. ROTH JOHN L. ROBINSON STEVEN A. ROSENBLUM JEANNEMARIE O’BRIEN JOSHUA A. FELTMAN JOHN R. SOBOLEWSKI JOHN F. SAVARESE WAYNE M. CARLIN GEORGE A. KATZ (1965 -1 9 8 9) ELAINE P. GOLIN STEVEN WINTER SCOTT K. CHARLES STEPHEN R. D iPRIMA JAMES H. FOGELSON (1967 - 1 9 91) EMI L A. KLEINHAUS EMILY D. JOHNSON JODI J. SCHWARTZ NICHOLAS G. DEMMO LEONARD M. ROSEN (1965 - 2 0 14 ) KARESSA L. CAIN JACOB A. KLING ADAM O. EMMERICH IGOR KIRMAN RONALD C. CHEN RAAJ S. NARAYAN RALPH M. LEVENE JONATHAN M. MOSES OF C O UN S EL GORDON S. MOODIE VIKTOR SAPEZHNIKOV RICHARD G. MASON T. EIKO STANGE DONGJU SONG MICHAEL J. SCHOBEL MARTIN J.E. ARMS ERIC S. ROBINSON DAVID M. SILK JOHN F. LYNCH BRADLEY R. WILSON ELINA TETELBAUM MICHAEL H. BYOWITZ PATRICIA A. ROBINSON* ROBIN PANOVKA WILLIAM SAVITT GRAHAM W.
    [Show full text]
  • Analyst's Conferences Tuesday, November 25, 2014
    Analyst's conferences Tuesday, November 25, 2014 Room London Sector Pharma / Biotech Time Company name Speaker 09:30-10:00 aap Implantate AG Bruke Seyoum Alemu, Chairman of the Management Board/CEO Marek Hahn, Member of the Management Board/CFO Sector Pharma / Biotech Time Company name Speaker 11:00-11:30 Eckert & Ziegler AG* Dr. Andreas Eckert, CEO Ron Littmann, CFO Sector Pharma / Biotech Time Company name Speakers 13:00-13:30 4SC AG Dipl. Kfm. Enno Spillner, CEO & CFO Jochen Orlowski, Head of Corporate Communications & Investor Relations 13:30-14:00 MorphoSys AG* Jens Holstein, Chief Financial Officer 14:00-14:30 Affimed N.V.* Dr. Adi Hoess, CEO Dr. Florian Fischer, CFO 14:30-15:00 PAION AG Dr Wolfgang Söhngen, CEO Abdelghani Omari, CFO 15:00-15:30 SYGNIS AG Pilar de la Huerta, CEO/CFO Michael Wolf, Vice President Finance & Accounting 15:30-16:00 Evotec AG Dr Werner Lanthaler, CEO 16:00-16:30 TRANSGENE Dr Hemanshu Shah, Vice President Medical Affairs PhD Elisabetta Castelli, Director Investor Relations 16:30-17:00 MOLOGEN AG Dr. Matthias Schroff, CEO 17:00-17:30 Medigene AG Peter Llewellyn-Davies, CFO 18:00-18:30 Santhera Pharmaceuticals Holding Ltd.* PhD Thomas Meier, CEO Dr. Roland Grimm, VP - Finance 18:30-19:00 Vita 34 AG* Dr. André Gerth, CEO Vita 34 Room Madrid Sector DAX / MDAX Time Company name Speakers 11:00-11:30 FUCHS PETROLUB SE Dr. Alexander Selent, Vice Chairman & CFO Dagmar Steinert, Head of Investor Relations 11:30-12:00 Axel Springer SE Claudia Thomé, Co-Head of Investor Relations Daniel Fard-Yazdani, Co- Head of Investor
    [Show full text]
  • Euro Stoxx® Multi Premia Index
    EURO STOXX® MULTI PREMIA INDEX Components1 Company Supersector Country Weight (%) SARTORIUS STEDIM BIOTECH Health Care France 1.59 IMCD Chemicals Netherlands 1.25 VOPAK Industrial Goods & Services Netherlands 1.15 BIOMERIEUX Health Care France 1.04 REMY COINTREAU Food, Beverage & Tobacco France 1.03 EURONEXT Financial Services France 1.00 HERMES INTERNATIONAL Consumer Products & Services France 0.94 SUEZ ENVIRONNEMENT Utilities France 0.94 BRENNTAG Chemicals Germany 0.93 ENAGAS Energy Spain 0.90 ILIAD Telecommunications France 0.89 DEUTSCHE POST Industrial Goods & Services Germany 0.88 FUCHS PETROLUB PREF Chemicals Germany 0.88 SEB Consumer Products & Services France 0.87 SIGNIFY Construction & Materials Netherlands 0.86 CARL ZEISS MEDITEC Health Care Germany 0.80 SOFINA Financial Services Belgium 0.80 EUROFINS SCIENTIFIC Health Care France 0.80 RATIONAL Industrial Goods & Services Germany 0.80 AALBERTS Industrial Goods & Services Netherlands 0.74 KINGSPAN GRP Construction & Materials Ireland 0.73 GERRESHEIMER Health Care Germany 0.72 GLANBIA Food, Beverage & Tobacco Ireland 0.71 PUBLICIS GRP Media France 0.70 UNITED INTERNET Technology Germany 0.70 L'OREAL Consumer Products & Services France 0.70 KPN Telecommunications Netherlands 0.68 SARTORIUS PREF. Health Care Germany 0.68 BMW Automobiles & Parts Germany 0.68 VISCOFAN Food, Beverage & Tobacco Spain 0.67 SAINT GOBAIN Construction & Materials France 0.67 CORBION Food, Beverage & Tobacco Netherlands 0.66 DAIMLER Automobiles & Parts Germany 0.66 PROSIEBENSAT.1 MEDIA Media Germany 0.65
    [Show full text]
  • DWS Equity Funds Semiannual Reports 2010/2011
    DWS Investment GmbH DWS Equity Funds Semiannual Reports 2010/2011 ■ DWS Deutschland ■ DWS Investa ■ DWS Aktien Strategie Deutschland ■ DWS European Opportunities ■ DWS Intervest ■ DWS Akkumula : The DWS/DB Group is the largest German mutual fund company according to assets under management. Source: BVI. As of: March 31, 2011. 4/2011 DWS Deutschland DWS Investa DWS Aktien Strategie Deutschland DWS European Opportunities DWS Intervest DWS Akkumula Contents Semiannual reports 2010/2011 for the period from October 1, 2010, through March 31, 2011 (in accordance with article 44 (2) of the German Investment Act (InvG)) TOP 50 Europa 00 General information 2 Semiannual reports 2010 DWS Deutschland 4 DWS Investa 10 2011 DWS Aktien Strategie Deutschland 16 DWS European Opportunities 22 DWS Intervest 28 DWS Akkumula 36 1 General information Performance ing benchmarks – if available – are also b) any taxes that may arise in connec- The investment return, or performance, presented in the report. All financial tion with administrative and custodial of a mutual fund investment is meas - data in this publication is as of costs; ured by the change in value of the March 31, 2011. c) the costs of asserting and enforcing fund’s units. The net asset values per the legal claims of the investment unit (= redemption prices) with the addi- Sales prospectuses fund. tion of intervening distributions, which The sole binding basis for a purchase are, for example, reinvested free of are the current versions of the simpli- The details of the fee structure are set charge within the scope of investment fied and the detailed sales prospec - forth in the current detailed sales accounts at DWS, are used as the basis tuses, which are available from DWS, prospectus.
    [Show full text]